Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

381 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
Lax SF, Pizer ES, Ronnett BM, Kurman RJ. Lax SF, et al. Among authors: kurman rj. Hum Pathol. 1998 Jun;29(6):551-8. doi: 10.1016/s0046-8177(98)80002-6. Hum Pathol. 1998. PMID: 9635673
Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma.
Zaino RJ, Kurman RJ. Zaino RJ, et al. Among authors: kurman rj. Semin Diagn Pathol. 1988 May;5(2):154-71. Semin Diagn Pathol. 1988. PMID: 3041509 Review.
Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators.
Seidman JD, Kurman RJ. Seidman JD, et al. Among authors: kurman rj. Hum Pathol. 2000 May;31(5):539-57. doi: 10.1053/hp.2000.8048. Hum Pathol. 2000. PMID: 10836293
Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study.
Zaino RJ, Kurman RJ, Brunetto VL, Morrow CP, Bentley RC, Cappellari JO, Bitterman P. Zaino RJ, et al. Among authors: kurman rj. Am J Surg Pathol. 1998 Nov;22(11):1379-85. doi: 10.1097/00000478-199811000-00008. Am J Surg Pathol. 1998. PMID: 9808130
Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.
Seidman JD, Kurman RJ. Seidman JD, et al. Among authors: kurman rj. Am J Surg Pathol. 1996 Nov;20(11):1331-45. doi: 10.1097/00000478-199611000-00004. Am J Surg Pathol. 1996. PMID: 8898837
Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors.
Burks RT, Sherman ME, Kurman RJ. Burks RT, et al. Among authors: kurman rj. Am J Surg Pathol. 1996 Nov;20(11):1319-30. doi: 10.1097/00000478-199611000-00003. Am J Surg Pathol. 1996. PMID: 8898836
The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group study.
Zaino RJ, Kurman RJ, Diana KL, Morrow CP. Zaino RJ, et al. Among authors: kurman rj. Cancer. 1995 Jan 1;75(1):81-6. doi: 10.1002/1097-0142(19950101)75:1<81::aid-cncr2820750114>3.0.co;2-f. Cancer. 1995. PMID: 7804981
Ovarian serous borderline tumors: the citadel defended.
Kurman RJ, Seidman JD. Kurman RJ, et al. Hum Pathol. 2000 Nov;31(11):1439-42. doi: 10.1016/s0046-8177(00)80020-9. Hum Pathol. 2000. PMID: 11112224 No abstract available.
The behavior of serous tumors of low malignant potential: are they ever malignant?
Kurman RJ, Trimble CL. Kurman RJ, et al. Int J Gynecol Pathol. 1993 Apr;12(2):120-7. doi: 10.1097/00004347-199304000-00006. Int J Gynecol Pathol. 1993. PMID: 8463035 Review.
Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance.
Salani R, Kurman RJ, Giuntoli R 2nd, Gardner G, Bristow R, Wang TL, Shih IM. Salani R, et al. Among authors: kurman rj. Int J Gynecol Cancer. 2008 May-Jun;18(3):487-91. doi: 10.1111/j.1525-1438.2007.01039.x. Epub 2007 Aug 10. Int J Gynecol Cancer. 2008. PMID: 17692090
381 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback